Aetna $2.56 Million Settlement for Improper Denial of Lumbar Disc Replacement Surgery Claims
The Aetna $2.56 Million Settlement for Improper Denial of Lumbar Disc Replacement Surgery Claims settlement offers $2.56M in total, with individual payouts of $55K to eligible claimants who have coverage under an erisa-governed aetna health plan (either self-funded or fully insured). The deadline to file is September 10, 2026. Proof of purchase is required.
Deadline: September 10, 2026
Total amount allocated for all claims
Estimated amount per eligible claim
Yes. Claimants must submit documentation supporting: (1) that they had (or plan to undergo) single-level L-ADR, such as operative report, clinical records, and/or detailed payment records; (2) that they made payment, such as checks, wire receipts, invoices, or other reasonable proof of payment; and (3) the specific amount of unreimbursed net out-of-pocket costs claimed. For future surgeries for current members, they must include a treating surgeon attestation or letter stating the procedure is medically necessary. For former members seeking reimbursement for a future surgery, they must also provide proof of payment after the surgery. If the administrator denies for insufficient documentation, claimants have 60 days to provide additional information and may request reconsideration within 60 days.
Settlement Summary
Lumbar artificial disc replacement (L-ADR) is a spine surgery used to relieve certain back problems by replacing a damaged disc. In this case, patients covered by health plans administered or insured by Aetna that were governed by the federal ERISA law said Aetna refused to pay for “single-level” L-ADR by labeling it experimental or investigational. Because ERISA plans often provide coverage through private employer arrangements, coverage decisions are frequently made through a plan’s internal review process—then, if necessary, challenged in court. The lawsuit was filed to address claims denials that class members said were improperly handled within that ERISA framework, resulting in some patients paying out of pocket for surgery after their requests were rejected. Aetna agreed to resolve the dispute through a class settlement worth $2.56 million, creating a pathway for eligible people to seek reimbursement of documented out-of-pocket costs (up to $55,000 for past surgeries) or, in certain circumstances, obtain reviewed coverage for future surgery if a surgeon attests the procedure is medically necessary. The settlement matters because it doesn’t just compensate affected patients—it also signals scrutiny of how insurers decide whether procedures are “experimental” under ERISA-governed plan terms, and it provides clear deadlines and documentation rules for class members to pursue relief. Similar disputes have appeared across the insurance industry where patients challenge medical-necessity determinations and investigational-status classifications, and these fights often intersect with ERISA’s requirement for fair plan adjudication and, depending on plan rules and legal standards, different levels of court review of insurer decisions. Broader implications extend to how health plans evaluate emerging medical technologies—especially expensive surgeries—using medical evidence, policies, and utilization-management criteria, all while balancing cost containment against patient access. In the spine-technology arena, where evidence can evolve and insurers may issue coverage policies that change over time, settlements like this can influence how both providers document necessity and how insurers justify medical determinations during claims and appeals. For patients and practitioners, it also reinforces that timing, eligibility status (current versus former Aetna members), and regulatory context (ERISA plan governance and review standards) can determine whether a denial can be challenged successfully or whether settlement benefits may be available. The class action settlement therefore offers a defined remedy to resolve alleged improper denials while highlighting the ongoing tension between innovation in care and insurance coverage rules.
Entities Involved
Related Topics
Eligibility Requirements
- Have coverage under an ERISA-governed Aetna health plan (either self-funded or fully insured)
- Received a mailed settlement notice
- Have Aetna denied a request/claim for single-level lumbar artificial disc replacement (L-ADR) as experimental/investigational during the specified time windows
- For the Hendricks action: denial occurred between Aug. 7, 2016 and Feb. 8, 2023 (subject to abuse of discretion review)
- For the Howard action: denial occurred between March 4, 2019 and Feb. 8, 2023 (subject to de novo review)
- Be a current Aetna ERISA member who has not yet had the surgery and seeks coverage under the settlement, or be a former Aetna ERISA member who has not had the surgery and lacks other L-ADR coverage and cannot reasonably obtain it
- For reimbursement: have net out-of-pocket payments to the medical provider(s) for the surgery that were not reimbursed
- Exclusions: denials after Feb. 8, 2023
- Exclusions: had coverage for L-ADR through another plan/insurer/Medicare/reimbursement source and owe no reimbursement beyond standard patient cost-sharing, or could reasonably enroll in individual coverage that includes L-ADR
Featured Investigations
Important Notice About Filing Claims
Submitting false information in a settlement claim is considered perjury and will result in your claim being rejected. Fraudulent claims harm legitimate class members and may result in legal consequences.
If you are unsure about your eligibility for this settlement, please visit the official settlement administrator’s website using the link provided above. Review the eligibility criteria carefully before submitting a claim.
Class Action Champion is an independent information resource and is not affiliated with any settlement administrator, law firm, or court. We provide settlement information as a service to help connect eligible class members with legitimate settlements.